Neurological Surgery Doctors in Elgin, IL Accepting Medicare

5 Neurological Surgery doctors found. Showing 1 - 5

Mr. Christopher J Cascino, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 901 Center St, Ste 3003, Elgin, IL 60120 Phone: 847-695-6611    Fax: 847-695-8069

Dr. Safwan Barakat, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1425 N Mclean Blvd, Ste 550, Elgin, IL 60123 Phone: 847-741-1610    Fax: 847-741-1798

Dr. Richard William Broderick, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1435 N Randall Rd Ste 107, Elgin, IL 60123 Phone: 224-359-0130    Fax: 224-359-0129

Mr. Dennis Yk Wen, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 87 N Airlite St Ste 220, Elgin, IL 60123 Phone: 847-695-6611    Fax: 847-695-8069

Mr. Young Chung, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 901 Center St, Ste 305, Elgin, IL 60120 Phone: 847-695-6611    Fax: 847-695-8069

News Archive

Highly efficient ChIP assay kit for FFPE samples

Chromatrap®, a business unit of Porvair Sciences, has introduced a new Formaldehyde Fixed Paraffin-Embedded (FFPE) ChIP Kit which overcomes the widely acknowledged shortfalls of the technique.

Insurers charging companies more if workers have unhealthy lifestyles

A Towers Watson survey found that the percentage of employer-sponsored policies that impose lifestyle-related financial penalities have doubled in the last two years.

Research findings could pave way for synthesis of biologically active oligopeptides

The research community and pharmaceutical industry have had a long-standing interest in developing peptide-based therapeutics owing to their high target specificity, potent activity, and small size relative to protein-based biologics.

First investigational treatment for infantile-onset SMA shows promising results in clinical trial

A major milestone was reached when nusinersen, an investigational treatment for spinal muscular atrophy (SMA), was shown to significantly improve achievement of motor milestones in babies with infantile-onset SMA, according to an interim analysis of the double-blind, randomized, placebo controlled Phase 3 clinical trial called ENDEAR.

AASLD, TFAH report calls for action to help identify Americans living with HBV, HCV

The American Association for the Study of Liver Diseases and the Trust for America's Health issued a new report today calling for action to be taken to transform how the country deals with viral hepatitis – to help identify millions of Americans who know they are living with chronic forms of hepatitis B and C and to assure access to treatment for all who need it, to prevent even more Americans from becoming infected.

Read more Medical News

› Verified 8 days ago